In 2024, the U.S. Drug Enforcement Administration (DEA) indicated which they intend to reclassify cannabis as being a Schedule III drug. This rescheduling will realize that cannabis has genuine medical purposes and will help open the doorway to research on other potential therapy works by using. these products and solutions https://mypresspage.com/story5098145/facts-about-disposable-thc-vapes-uk-revealed